SGI-110 with irinotecan
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SGI-110 with irinotecan, covering 2020-09-14 to 2020-09-14. Get the full timeline:
Most recent: Clinical Trial Update: Phase I/II Study of SGI-110 With Irinotecan Versus Regorafenib or TAS-102 in Metastatic Colorectal Cancer [Phase 1, Phase 2]